Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry" by Sparks et al.
Ronald F Van VollenhovenSander W TasMichael T NurmohamedPublished in: Annals of the rheumatic diseases (2021)